Liposomes |
CRISPR‐Cas9 ribonucleoprotein complex |
Subretinal injection |
Inducing efficient genome editing in vivo |
[
94
]
|
Nanostructured lipid carriers |
Dasatinib |
Topical administration |
Increasing the solubility of dasatinib, sustaining drug release, reducing ocular toxicity, and facilitating its penetration into cornea |
[
23b
]
|
Solid lipid nanoparticles |
RS1 DNA plasmid |
Intravitreal injection |
Improvement of retinal structure by extending therapeutic period up to 2 weeks |
[
22a
]
|
DSPE‐PEG2000‐cRGD nanomicelle |
Flurbiprofen |
Eye drops |
Specifically targeted combining to integrin receptors on cornea surface and facilitated rapid mucoadhesion |
[
28
]
|
Boronic acid‐rich dendrimer |
Superoxide dismutase |
Intravitreal injection |
Protecting retinal function and reducing cell apoptosis by high levels of cellular uptake without immunogenicity and cytotoxicity |
[
33
]
|
DNA/PLGA hybrid hydrogel |
Dexamethasone |
Topical administration |
Improving dexamethasone accumulation and mediating gradual dexamethasone release |
[
4
]
|
Chitosan‐based self‐assembly nanofilms |
Heparin |
Cornea in situ self‐assembly |
Rescuing corneal defective wound healing |
[
45
]
|
Mesenchymal stem cells‐derived exosomes |
– |
Intravitreal injection/eye drops |
Significantly anatomical and functional restoration of retina, optic nerve, or cornea by modulating angiogenesis and inflammation, and improving immunomodulation and tissue regeneration |
[
66
,
67
,
68
]
|
Palladium‐coated gold nanorods |
– |
Being pasted to lacrimal gland |
Sensing diverse visible light irradiations and spontaneously responded by heating up to secrete more tears to prevent dry eye |
[
50
]
|
Nanoceria |
Doxorubicin |
Intravitreal injection |
Sensitive to extracellular acidic pH conditions, targeted to tumor cells, instantaneously inducing ROS, and releasing doxorubicin intracellularly to enhance the chemotherapeutic activity in retinoblastoma cells |
[
122a
]
|
Gold nanoparticles‐based nanobubbles |
Hyaluronic acid |
Intravitreal injection |
Mechanically ablating the vitreous opacities upon local pulsed‐laser illuminates to generate vapor nanobubbles |
[
51
]
|
Dichalcogenides quantum dots |
— |
Eye drops |
Antibacterial agent with a fast response and no reliance on light |
[
57
]
|
Mesoporous silica nanoparticles |
Bevacizumab |
Intravitreal/subconjunctival injection |
Suppressing corneal and retinal neovascularization |
[
62
]
|
Spermidine‐derived carbon quantum dots |
— |
Eye drops |
Strong antibacterial capabilities for treatment of bacterial keratitis |
[
10c
]
|
Graphene‐coated contact lens |
— |
Wearing on the ocular surface |
Monitoring changed water evaporation rate and protecting eyes from electromagnetic wave damage |
[
59
,
60
]
|
Thermosensitive triblock copolymer |
Acriflavine hydrochloride and sunitinib malate |
Topical administration |
Increasing the intraocular absorption of hydrophilic and hydrophobic drugs and extending the drug–ocular–epithelium contact time |
[
140
]
|
PEG‐b‐poly(propylene sulfide) nanomicelles |
Actin depolymerizer latrunculin A |
Intracameral injection |
Selectively modulating stiffness of Schlemm's canal cells for therapeutic reducing intraocular pressure |
[
105
]
|